nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anti-müllerian hormone levels are reduced in women living with human immunodeficiency virus compared to control women: a case–control study from Copenhagen, Denmark
|
Wessman, Maria |
|
|
4 |
2 |
p. 123-127 |
artikel |
2 |
Bioequivalent pharmacokinetics for generic and originator hepatitis C direct-acting antivirals
|
Hill, Andrew |
|
|
4 |
2 |
p. 128-131 |
artikel |
3 |
Ethical challenges in developing an educational video to empower potential participants during consent processes in HIV cure research in South Africa
|
Staunton, Ciara |
|
|
4 |
2 |
p. 99-102 |
artikel |
4 |
Heterogeneity in hepatitis C treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access
|
Scott, Nick |
|
|
4 |
2 |
p. 108-114 |
artikel |
5 |
Highlights from the 8th International Workshop on HIV Persistence during Therapy, 12–15 December 2017, Miami, FL, USA
|
Psomas, Christina K. |
|
|
4 |
2 |
p. 132-142 |
artikel |
6 |
Impact of an educational video as a consent tool on knowledge about cure research among patients and caregivers at HIV clinics in South Africa
|
Hendricks, Melany |
|
|
4 |
2 |
p. 103-107 |
artikel |
7 |
Implementation of hepatitis C cure in Australia: one year on
|
Richmond, Jacqueline A. |
|
|
4 |
2 |
p. 115-117 |
artikel |
8 |
In memoriam David Cooper
|
|
|
|
4 |
2 |
p. i |
artikel |
9 |
Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission
|
Puthanakit, Thanyawee |
|
|
4 |
2 |
p. 61-65 |
artikel |
10 |
Latent HIV dynamics and implications for sustained viral suppression in the absence of antiretroviral therapy
|
Murray, John M. |
|
|
4 |
2 |
p. 91-98 |
artikel |
11 |
Outpatient directly observed therapy for hepatitis C among people who use drugs: a systematic review and meta-analysis
|
McDermott, Cara L. |
|
|
4 |
2 |
p. 118-122 |
artikel |
12 |
Safety and pharmacokinetics of dolutegravir in HIV-positive pregnant women: a systematic review
|
Hill, An.drew |
|
|
4 |
2 |
p. 66-71 |
artikel |
13 |
Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?
|
Hill, Andrew |
|
|
4 |
2 |
p. 72-79 |
artikel |
14 |
The impact of HIV prevalence, conflict, corruption, and GDP/capita on treatment cascades: data from 137 countries
|
Levi, Jacob |
|
|
4 |
2 |
p. 80-90 |
artikel |